Avanza Fonder’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.08M Sell
78,109
-16,331
-17% -$1.46M 0.18% 107
2026
Q1
$6.78M Sell
94,440
-8,191
-8% -$631K 0.19% 110
2025
Q4
$8.14M Buy
102,631
+7,149
+7% +$564K 0.21% 91
2025
Q3
$7.2M Buy
95,482
+9,600
+11% +$658K 0.19% 94
2025
Q2
$5.92M Sell
85,882
-5,480
-6% -$359K 0.18% 104
2025
Q1
$6.22M Sell
91,362
-14,342
-14% -$858K 0.2% 96
2024
Q4
$4.75M Buy
+105,704
New +$5.93M 0.14% 124

Other funds holding CVS

Avanza Fonder's CVS Position: Q2 2026 in Review

Avanza Fonder reduced its CVS Health (CVS) stake by 17% in Q2 2026, selling an estimated $1.46M and leaving 78,109 shares worth $8.08M. The position accounts for 0.18% of the portfolio, ranked #107.

Avanza Fonder first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.14M in Q4 2025. 854 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Avanza Fonder held 78,109 shares of CVS Health worth $8.08M as of Q2 2026.
  • Avanza Fonder sold 16,331 CVS Health shares in Q2 2026, an estimated $1.46M.
  • CVS Health made up 0.18% of Avanza Fonder's portfolio in Q2 2026, its #107 holding.
  • Avanza Fonder first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's CVS Health position peaked at $8.14M in Q4 2025.
  • 854 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.